(Reuters) – Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product innovations.
The company said the investment is in addition to its 300 million pound ($372.5 million) annual spending in R&D.
The Richmond facility is one of the three R&D centres of excellence for Haleon, along with Weybridge, UK and Suzhou, China.
($1 = 0.8053 pounds)
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Arun Koyyur)
